HouseH.R. 10483119th Congress
Bone Marrow Radiation Shielding Act
Full Text
Official text as published. Use Ctrl+F / Cmd+F to search within the document.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10483 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. R. 10483
To direct the Assistant Secretary of Defense for Nuclear, Chemical, and
Biological Defense, Policy and Programs to seek to enter into an
agreement with a University Affiliated Research Center affiliated with
United States Strategic Command to conduct an independent scientific
assessment with respect to bone marrow radiation shielding for nuclear
survivability.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 17, 2026
Mr. Bacon introduced the following bill; which was referred to the
Committee on Armed Services
_______________________________________________________________________
A BILL
To direct the Assistant Secretary of Defense for Nuclear, Chemical, and
Biological Defense, Policy and Programs to seek to enter into an
agreement with a University Affiliated Research Center affiliated with
United States Strategic Command to conduct an independent scientific
assessment with respect to bone marrow radiation shielding for nuclear
survivability.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Bone Marrow Radiation Shielding
Act''.
SEC. 2. INDEPENDENT ASSESSMENT OF BONE MARROW RADIATION SHIELDING FOR
NUCLEAR SURVIVABILITY.
(a) Assessment Required.--Not later than 30 days after the date of
the enactment of this Act, the Assistant Secretary of Defense for
Nuclear, Chemical, and Biological Defense, Policy and Programs shall
seek to enter into an agreement with a University Affiliated Research
Center affiliated with United States Strategic Command to conduct an
independent scientific assessment on whether preserving the viability
of bone marrow using partial body radiation shielding can improve the
survivability of an individual exposed to gamma radiation as compared
to an individual without such protection.
(b) Elements.--The assessment required under subsection (a) shall
examine peer-reviewed scientific literature, laboratory studies and
relevant experimental data to evaluate the comparative effectiveness of
preserving bone marrow using partial body radiation shielding with
respect to--
(1) the likelihood of developing Acute Radiation Syndrome;
(2) the severity of Acute Radiation Syndrome when it
occurs; and
(3) overall mortality rates following gamma radiation
exposure.
(c) Report.--Not later than 150 days after the date of the
enactment of this Act, the Assistant Secretary shall submit to the
Committees on Armed Services of the House of Representatives and the
Senate a report on the assessment required under subsection (a) that
includes the findings of such assessment.
<all>